Pacific Biosciences designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes.
Pacific Biosciences offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. It also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits.
Pacific Biosciences‘ customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, and Latin America.
Joseph Bonventre and Stephen Turner founded Nanofluidics in 2000 that laterbecame Pacific Biosciences. Its headquarters is in Menlo Park in California.